Johnson & Johnson to Host Medical Devices & Diagnostics Review

NEW BRUNSWICK, N.J., Oct. 25, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a Medical Devices & Diagnostics business review for the investment community beginning at 8:30 a.m. (Eastern Time) on Thursday, November 1st at the Hyatt Regency Hotel in New Brunswick, N.J.

The program will include presentations by Johnson & Johnson's senior management representing our Medical Devices & Diagnostics segments.  Dominic Caruso, Vice President, Finance and Chief Financial Officer will open the meeting.  

A live webcast will be available through www.investor.jnj.com.  This webcast is optimized for mobile streaming on iOS devices such as iPhones, iPods, and iPads.  A replay and podcast will be available approximately two hours after the meeting concludes.

SOURCE Johnson & Johnson

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.